The genetic technologies company, Genetic Technologies Limited, has announced a $2 million registered direct offering, involving the sale of 1,000,000 American Depositary Shares (ADSs) at a purchase price of $2.00 per ADS. Additionally, the company will issue unregistered warrants to purchase up to 1,000,000 ADSs. The offering aims to drive revenue, support sales and marketing initiatives, expand into new markets, fund research and development, and cover general corporate purposes. The transaction is expected to close on April 22, 2024. For more information, visit Genetic Technologies Limited’s website.
Genetic Technologies Announces $2 Million Offering for Expansion and Product Development, Australia
Date:
Updated: [falahcoin_post_modified_date]